Padlock Therapeutics

Padlock is developing medicines targeting protein-arginine deiminases (PADs), enzymes with an important role in the generation of autoantigens, inflammation, and immune complex formation in autoimmune diseases. Padlock intends to explore the full biological and therapeutic footprint of protein deimination by PADs.

Headquarters Cambridge, MA
Twitter @PadlockTx​
Pipeline Preclinical
Partners GlaxoSmithKline